Risk Associated with Various Definitions of Family History of Coronary Heart Disease

Size: px
Start display at page:

Download "Risk Associated with Various Definitions of Family History of Coronary Heart Disease"

Transcription

1 American Journal of Epidemiology Copyright 998 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 47, No. 2 Printed in U.S.A. Risk Associated with Various Definitions of Family History of Coronary Heart Disease The Newcastle Family History Study II Jonathan S. Silberberg, ' 2 John Wlodarczyk, Jayne Fryer, Randall Robertson, and Michael J. Hensley The authors carried out a population-based case-control study to estimate the risk of an acute coronary disease event associated with various definitions of a family history of coronary heart disease (CHD). A detailed family history questionnaire was completed by 403 cases and 236 controls in Newcastle, New South Wales, Australia from 992 to 994. Odds ratios of an acute coronary disease event adjusted for proband age and sex ranged from 2.7 (95% confidence interval (Cl).8-4.) for the simplest definition (one or more first-degree relatives with CHD at any age) to 5.4 (.7-6.8) for the most stringent definition (two or more first-degree relatives with CHD before age 55 years). In a series of nested models, the authors examined the improvement in model fit as each component of the detailed family history was added. Additional information was provided by accounting for "don't know" responses, the number of affected relatives, the age of the affected relative, and whether the first-degree relative was a sibling rather than a parent. The results were similar when the data were analyzed as a cohort design with proband disease status as the exposure variable. The authors suggest that, to facilitate preventive efforts in a population, more detailed family history definitions should be used to better target high risk subjects. Am J Epidemiol 998;47:33-9. age of onset; case-control studies; coronary disease; family characteristics; genetics A strong family history of coronary heart disease (CHD) is the major predisposing factor to the development of CHD. Despite this, family history of CHD is given no more status than that of other risk factors in current guidelines for the treatment of dyslipidemia in the United States (), Europe (2), Australia (3), or New Zealand (4), and some treatment algorithms based on absolute risk (5) do not consider family history at all. When family history is included, it is rarely used precisely. Usual definitions of a positive family history (such as having a first-degree relative with CHD) do not consider all of the information available. As has been shown in the Utah population (6), the risk associated with a positive family history is Received for publication October 30, 996, and accepted for publication August 27, 997. Abbreviations: CHD, coronary heart disease; Cl, confidence interval; MONICA, Monitoring Trends and Determinants in Cardiovascular Disease; OR, odds ratio. Discipline of Medicine, Faculty of Medicine and Health Sciences, The University of Newcastle, Callaghan, Newcastle, New South Wales, Australia. 2 Cardiovascular Unit, John Hunter Hospital, Newcastle, New South Wales, Australia. Reprint requests to Dr. Jonathan Silberberg, Department of Medicine, John Hunter Hospital, Locked Bag No., Hunter Region Mail Centre, NSW 230, Australia. greater when accounting for the number of at-risk relatives or the age at which CHD first became evident. To better identify those at high risk for CHD in a typical Australian population, we sought to ascertain the prevalence of various definitions of a positive family history and to estimate the additional information provided by more complex definitions. We evaluated the risk using a traditional case-control approach and also by comparing cohorts of case and control relatives. MATERIALS AND METHODS The Family History Study was a population-based study of family history of CHD conducted in Newcastle, New South Wales, Australia, from 992 to 994. Details of the sampling frame, characteristics of participants, and the accuracy of recall of family history are described in Paper I (7) accompanying. Briefly, we enrolled suspected CHD cases among males aged under 65 years and among females aged under 70 years who were admitted to one of the Hunter region district hospitals with a suspected acute coronary disease syndrome (myocardial infarction or unstable angina) who were registered by the Newcastle MONICA project (8) (Monitoring Trends and Determinants in Cardiovascular Disease). Controls were 33

2 34 Silberberg et al. invited at random from the Hunter region of the New South Wales electoral roll. In the main analysis, we report the odds ratio of an acute coronary disease event based on comparison of self-reported family history between cases and controls who completed the detailed family history questionnaire. Family history definitions We defined a positive family history in several ways, according to the number of affected relatives, their relationship to the proband, and their age when CHD first became evident. Simple definitions ranged from "one or more first-degree relatives with CHD at any age" to "two or more first-degree relatives with CHD before age 55 years." Within each of these definitions, we further defined which relative was affected (sibling or parent, father or mother, brother or sister). Because few children were affected, they were excluded from the main analysis. Statistical methods Case-control approach. We performed logistic regression analysis (SAS Institute, Cary, North Carolina) with disease status (case/control) as the outcome variable. The explanatory variables were family history of CHD and proband sex and age (continuous). We included the proband's smoking status, history of high blood pressure, high cholesterol, and diabetes mellitus as covariates. We first fitted a series of mutually exclusive models and derived odds ratios for each of the family history definitions. To account for "don't know" responses, we assigned an indicator (dummy) variable for "don't know" to each family history definition. Nested models. We tested the additional information afforded by more precise definitions of family history in a series of nested models (9) to study the improvement in goodness-of-fit as each component family history term was added. For instance, the importance of age at onset of CHD in the relative was examined by comparing the model which included both "one or more affected relatives at any age" and "one or more affected relatives before age 60 years" with that including the "any age" term alone. The coefficient for the "before age 60 years" term addresses the odds ratio associated with onset before age 60 years compared with any age. Cohort approach. Khoury and Beaty (0) have proposed an alternative to treating family history as an "exposure" in case-control studies by transforming the analysis to a cohort design. We evaluated the cohort of relatives for cumulative risk of CHD, with proband disease status (case or control) as the "exposure" variable. We conducted several analyses for first-degree, second-degree, and all relatives combined as well as parents, siblings, brothers, and sisters. We fitted the models of Zeger and Liang () using the SAS macro GEE version 2.03 (SAS Institute, Cary, North Carolina) in order to estimate the within-family correlation in risk with relatives' age and sex and proband disease status in the model. We compared the risk estimates with those derived from the traditional case-control analysis. Sensitivity analyses To study the effect of misclassifying "don't know" to "no," we pooled these as the reference category. Because our validation study indicated that most misclassification of CHD was to "other heart disease" rather than "no heart disease," we also conducted the analyses based on family history of all heart disease, rather than CHD alone. In other sensitivity analyses, we used incident rather than prevalent cases and fatal CHD in relatives rather than all affected relatives. To address the impact of selection bias, we repeated the comparisons of simple family history definitions using the larger data set of all short questionnaire respondents (,08 cases and 574 controls) rather than the smaller number who completed the detailed questionnaire. RESULTS A detailed family history questionnaire was completed by 432 MONICA subjects and 248 electoral roll subjects. We excluded 29 MONICA subjects because they had a final diagnosis other than "definite" or "possible" myocardial infarction and 2 electoral roll subjects who reported a history of prior angina or myocardial infarction. The demographic particulars of the 403 cases and 236 controls who completed the detailed questionnaire were similar to those who completed the short questionnaire only, as described in Paper I (7). Cases were older and included a higher proportion of males. They more often reported prior cigarette smoking, a history of hypertension, or diabetes mellitus. Controls were more likely to be employed full time and to report an education level beyond high school. Case-control approach The odds ratios associated with various definitions of family history of CHD, adjusted for proband age and sex, are given in table. The odds ratios ranged from 5.4 (95 percent confidence interval (CI).7-6.8) for the most stringent definition (two or more first-degree relatives with CHD before age 55 years; Am J Epidemiol Vol. 47, No. 2, 998

3 Risk Associated with Family History of Coronary Heart Disease 35 TABLE. Odds ratios (OR) and 95% confidence interval (Cl) associated with family history of coronary heart disease (CHD) in the Newcastle Family History Study, Australia, * Family history First-degree relatives (parents, siblings) with CHD at age <55 years > with CHD at age <60 years > with CHD at any age >2 with CHD at age <55 years >2 with CHD at age <60 years >2 with CHD at any age Parents -2 with CHD at age <60 years -2 with CHD at any age Siblings (brothers and sisters) > with CHD at age <60 years > with CHD at any age Prevalence (%:) Cases Controls No.not "donl know" Cases Controls "Don't know" as a dummy variable ^ "Doni know" pooled with "no" ^ * Because "don't know" responses varied with the components of each definition, the number of infomnative subjects differs in each analysis; the prevalence shown is that with "don't knows" included. f Odds ratio based on detailed family history questionnaire and adjusted for proband age and sex. prevalence in sample = 2 percent) to 2.7 (95 percent Cl.8-4.) for the simplest definition (one or more first-degree relatives with CHD at any age; prevalence in sample = 57 percent). Odds ratios for onset at any age were lower than for early onset, except where the affected relative was a sibling (hence closer in age to the proband). Surprisingly, the estimates for an affected father were greater than for an affected mother, but the confidence limits about the difference were wide. The odds ratios for one or more affected relatives are illustrated in figure. Nested models: improvement in fit with more detailed family history As our reference model, we chose the simplest family history definition (one or more first-degree relatives with CHD at any age) and compared the improvement in fit as further components of the family history were added. These analyses are summarized in table 2. at onset. The odds ratio associated with onset of CHD in a first-degree relative before age 60 years 00 or more first degree relatives father or more brothers - ormore -sisters in tn o to <o a) W V < of onset FIGURE. Odds ratios (and 95 percent confidence intervals) of an acute coronary disease event associated with various definitions of family history of coronary heart disease (CHD), according to age (years) at onset of CHD in relatives. Odds ratios are adjusted for proband age and sex, with "don't know" as the dummy variable. Am J Epidemiol Vol. 47, No. 2, 998

4 36 Silberberg et al. TABLE 2. Odds ratios (OR) and 95% confidence interval (Cl) and improvement in fit with addition of detailed family history terms in the Newcastle Family History Study, Australia, Te moared at onset of affected first-degree relatives Onset at age <60 years vs. onset at any age Onset at age <55 years vs. onset at any age Onset at age <55 years vs. onset at age <60 years No. of affected first-degree relatives >2 vs. >, at any age >2 vs., at age <60 years "Don't know" about first-degree relatives "Don't know" as dummy variable vs. "don't know" reset to "no," at any age "Don't know" as dummy variable vs. "don't know" reset to "no," at age <60 years Relationship of relative Sibling vs. any first-degree relative, at any age Sex of relative Mother vs. either parent, at any age Sister vs. any sibling, at any age Odds ratio* X Improvement in model fit * Odds ratio associated with the more detailed definition when compared with the other definition listed, t d.f., degrees of freedom. d.f.t 2 2 n value <0.000 < < < compared with onset at any age was 3.7 (95 percent Cl ). Onset before age 55 years did not add further to onset before age 60 years. Number of affected relatives. The odds ratios comparing two or more affected first-degree relatives with one or more affected were 2.5 (95 percent Cl.6-4.0) for onset of CHD at any age and.8 (95 percent Cl ) for onset of CHD before age 60 years. Relationship of relative. The odds ratio associated with the affected relative being a sibling rather than any first-degree relative (i.e., sibling or parent) was 2.6 (95 percent Cl.6-4.3). This was particularly important in younger probands (see below). Sex of relative. The coefficients for affected mother (vs. any parent) and sister (vs. any sibling) were not significant (improvement, x* = 0.0 and 0.8, respectively). Effect modification by proband age and sex. All odds ratios associated with the family history definitions were greater at younger ages (table 3). There was little modification by gender. In younger probands, an affected sibling was significantly associated with risk even in families with a parent already affected before age 60 years (odds ratio (OR) for sibling adjusted for parent = 5.8; improvement, )f 8.4, 2 degrees of freedom (df), p < 0.000). In older probands, the improvement was less (x 2 = 3.6, 2 df, p = 0.6). Favorable family history. For the definition "no TABLE 3. Odds ratios (OR) and 95% confidence intervals (Cl) associated with family history definitions, by age and sex of the proband, in the Newcastle Family History Study, Australia, Family history definition age No. Of cases No. of controls first-degree relatives with CHD* at any age ORf 2 first-degree relatives with CHD at arry age first-degree relatives with CHD al age <60 years 2 first-degree relatives with CHD at age <60 years siblings with CHD at any age Males <55 55 Females * CHD, coronary heart disease. t Odds ratio with "don't know" as a dummy variable. Am J Epidemiol Vol. 47, No. 2, 998

5 Risk Associated with Family History of Coronary Heart Disease 37 first-degree relative with CHD and two or more not affected by age 75 years," the odds ratio was 0.3 (95 percent CI ). This definition was met by 9/403 cases (2 percent) and 8/236 controls (8 percent). The more common definition "no first-degree relative with CHD and two or more not affected by age 70 years" yielded an odds ratio of 0.45 (95 percent CI ). "Don't know" is significantly associated with risk of CHD. The odds ratios for those who reported "don't know" compared with those who reported "no" were different from unity for most family history definitions. For instance, "don't know whether any firstdegree relative had CHD before age 60 years" yielded an odds ratio of.9 (95 percent CI ). Sensitivity analyses Misclassifying "don't know" responses. When all "don't knows" were reclassified as "no," the adjusted odds ratios associated with a positive family history were slightly reduced, ranging from 2.4 (95 percent CI.6-3.5) for "one or more first-degree relatives with CHD at any age" to 5. (95 percent CI.6-5.9) for "two or more first-degree relatives with CHD before age 55 years." Family history of all heart disease. For family history of all heart disease, the frequencies and odds ratios were similar to those for CHD. For instance, the odds ratio associated with "one or more first-degree relatives with heart disease at any age," adjusted for proband age and sex, was 2.5 (95 percent CI.7-3.8). Incident cases only. Of 403 cases who completed the detailed questionnaire, 243 (60 percent) had no prior history of CHD. All odds ratios were similar when restricted to this group. Fatal affected relatives only. Using the short questionnaire,,025 probands reported an affected firstdegree relative, with 734 first-degree relatives who had died of CHD. The odds ratio associated with one or more fatally affected first-degree relatives at any age was 2.4 (compared with 2.7 for either fatal or nonfatal). When adjusted for the age of the proband and with "don't know" responses excluded, the odds ratio was 2. (p < 0.000). Impact of selection bias: analysis of short family history only A short family history which did not include the age of affected relatives was available for,08 cases and 574 controls. Disagreement between the short and detailed family history was infrequent (leading to a change of family history status in only 6 percent of subjects). Adjusted odds ratios were slightly smaller than those for the main analysis (for one or more affected first-degree relatives at any age, OR = 2.5, 95 percent CI ; for one or more affected siblings, OR = 2.7, 95 percent CI ). Adjustment for other risk factors In multivariate analyses, the major CHD risk factors were all significantly associated with an acute coronary disease event. Odds ratios were 2.0 (95 percent CI.3-3.0) for having ever smoked, 6.8 (95 percent CI ) for diabetes mellitus, 2.4 (95 percent CI.6-3.6) for high blood pressure, and 2.9 (95 percent CI.9-4.5) for high cholesterol. When these risk factors were included in the model, the odds ratios for all family history definitions were slightly reduced (e.g., for one or more first-degree relatives with CHD at any age, OR = 2.3, 95 percent CI.5-3.6, and for one or more first-degree relatives with CHD before age 60 years, OR = 4.3, 95 percent CI ). Cohort approach The number of relatives, within-family correlations in risk, and odds ratios derived in each analysis using the cohort approach are shown in table 4. In firstdegree relatives (excluding children), the odds ratio was 2.3 (95 percent CI.6-3.); in siblings, 3.0 (95 percent CI.9-4.7); and in second-degree relatives,.5 (95 percent CI.0-2.2). The odds ratio for gender was.8 and that for age.07 (per year). The largest intraclass correlation in risk was 0.9 (for male siblings); correlations of 0.05 to 0.0 were more usual. DISCUSSION The estimates of coronary disease risk associated with a positive family history of CHD that we obtained are all similar to those reported by Hunt et al. (6) in the Utah population. When "don't knows" were reclassified as "no," the odds ratios remained large. This confirms that a detailed family history of CHD can be used to identify subjects at high or low risk of CHD even in a population where a high proportion of "don't know" responses is encountered. The prevalence of the various family history definitions we observed in the control series cannot be extrapolated to the general population without considering the selection and age stratification of our sample. Although the participation rate was low, we are reasonably sure that our risk estimates reliably reflect the source population. The analysis including 76 percent of eligible MONICA subjects and 62 percent of eligible electoral roll subjects based on a short family history gave similar estimates to the main analysis. We estimated the selection and recall biases explicitly. Even under a "worst case" scenario, the risk associated Am J Epidemiol Vol. 47, No. 2, 998

6 38 Silberberg et al. TABLE 4. Odds ratios and 95% confidence intervals (Cl), by model, under the cohort approach in the Newcastle Family History Study, Australia, * Model No. of relatives Parents and siblings,56 No. of families 57 Within-family correlation In disease 0.07 Model terms Sex Odds ratio, robust variance Male siblings Female siblings Second-degree relatives Sex with a strong family history of CHD remains substantial. When using the odds ratios derived from the casecontrol analysis as measures of relative risk, one must be mindful of biases intrinsic in the method. Khoury and Flanders (2) evaluated the impact of several family parameters. They showed that even when there are no differences in family size or age profile, the odds ratio from a case-control analysis may be biased in a positive (unfavorable) direction when the disease is prevalent among relatives or when the correlation in risk between relatives is small (as applies in the present study). Other factors which may introduce bias are unequal numbers or unequal age distribution of case and control relatives and early onset of disease (these factors are either neutral or are slightly favorable in this study). The magnitude of bias inherent in the case-control analysis can be seen by comparing odds ratios from the two approaches. When adjusted for age and sex, the definition "one or more first-degree relatives with CHD" yielded odds ratios of 2.7 (case-control) and 2.3 (cohort). Other odds ratios were similarly inflated, and the conclusions were generally unaltered. The high prevalence of CHD among relatives (approximately 30 percent) contributes the most to bias in the case-control analysis. Because CHD is more common in males, the bias will be stronger for fathers and brothers. This is likely to account for the finding that an affected father conferred higher risk than an affected mother (figure ). An alternative way to account for family size, age, and risk status is to derive family history scores or indexes which compare the family experience with that expected from population CHD rates. This enables the case-control format to be retained. We have applied published scores to these data and have derived two of our own, as reported elsewhere (3). Our data show clearly the value of looking beyond first-degree "yes/no" definitions. In addition to allowing for the number of affected relatives and their age at disease onset, we found the fit to be improved when distinguishing an affected sibling from an affected parent, particularly in younger probands. This observation is consistent with the findings of a major study of familial CHD in twins (4) but has not usually been considered in CHD risk estimation. Published estimates of risk associated with a family history of CHD have varied with the definition used and also with the inclusion of covariates in the model (5). It has been usual to pursue the effect of family history independent of other risk factors such as diabetes mellitus, high blood pressure, or high cholesterol. In this way, adjusted odds ratios of between.3 and 3.0 have been reported (5). It has been observed that running in families are several well-defined metabolic disorders whose major manifestation is premature atherosclerosis. As these phenotypes are better defined and entered in the model, the "independent" effect of family history will disappear entirely. In the population, a strong family history indicates how vigorously causal phenotypes should be sought. Even in those who do not have a clearly defined metabolic anomaly, family history serves as a marker of an underlying familial susceptibility to risk factors (2) and perhaps a stronger case for treatment. We recommend that evaluation of a family history of CHD includes the number of affected relatives and whether CHD became manifest before age 60 years. In younger probands, identifying those with an affected sibling appears particularly important. Am J Epidemiol Vol. 47, No. 2, 998

7 Risk Associated with Family History of Coronary Heart Disease 39 ACKNOWLEDGMENTS This paper was funded by Commonwealth Department of Human Services and Health (RADGAC) grant no. HS 335. REFERENCES. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report (Adult Treatment Panel II). JAMA 993;269: Pyoralla K, De Backer G, Graham I, et al. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Hypertension. Atherosclerosis. 994;0: National Heart Foundation of Australia. Guide to plasma lipids for doctors. Woden, ACT, Australia: National Heart Foundation of Australia, Dyslipidaemia Advisory Group on behalf of the Scientific Committee of the National Heart Foundation of New Zealand. 996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. NZ Med J 996;09: Haq IU, Jackson PR, Yeo WW, et al. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 995;346: Hunt SC, Willams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 986;39: Silberberg J, Wlodarczyk J, Fryer J, et al. Correction for biases in a population-based study of family history and coronary heart disease. The Newcastle Family History Study I. Am J Epidemiol 998; 47: Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation. 994;90: Miettinen OS. Theoretical epidemiology. New York: John Wiley & Sons, 985: Khoury MJ, Beaty TH. Applications of the case-control method in genetic epidemiology. Epidemiol Rev 994;6: Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 986;42; Khoury MJ, Flanders WD. Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 995;6: Fryer J, Silberberg JS, Wlodarczyk J, et al. Utility of two new family history measures for identifying high risk of coronary heart disease. Genet Epidemiol (in press). 4. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 994;330: Silberberg J. Family history of coronary heart disease: a window on disease mechanisms. Lipid Rev 994;8(2): Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 992; 36: Am J Epidemiol Vol. 47, No. 2, 998

who quit cigarette smoking

who quit cigarette smoking Rapid reduction in coronary risk for those who quit cigarette smoking Patrick McElduff and Annette Dobson Department of Statistics, University of Newcastle, New South Wales Robert Beaglehole and Rodney

More information

Epidemiological studies indicate that a parental or family

Epidemiological studies indicate that a parental or family Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women Howard D. Sesso, ScD, MPH; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD, MPH; Kathryn M. Rexrode,

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart

More information

Online Supplementary Material

Online Supplementary Material Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control

More information

Rates and patterns of participation in cardiac rehabilitation in Victoria

Rates and patterns of participation in cardiac rehabilitation in Victoria Rates and patterns of participation in cardiac rehabilitation in Victoria Vijaya Sundararajan, MD, MPH, Stephen Begg, MS, Michael Ackland, MBBS, MPH, FAPHM, Ric Marshall, PhD Victorian Department of Human

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Canada, like many developed countries, has

Canada, like many developed countries, has 23 Heart disease, family history and physical activity Jiajian Chen and Wayne J. Millar Abstract Objectives This article examines the association of family history of heart disease and leisure-time physical

More information

Passive smoking as well as active smoking increases the risk of acute stroke

Passive smoking as well as active smoking increases the risk of acute stroke 156 Tobacco Control 1999;8:156 160 Passive smoking as well as active smoking increases the risk of acute stroke Ruth Bonita, John Duncan, Thomas Truelsen, Rodney T Jackson, Robert Beaglehole Department

More information

Appropriate Statistical Methods to Account for Similarities in Binary Outcomes Between Fellow Eyes

Appropriate Statistical Methods to Account for Similarities in Binary Outcomes Between Fellow Eyes Appropriate Statistical Methods to Account for Similarities in Binary Outcomes Between Fellow Eyes Joanne Katz,* Scott Zeger,-\ and Kung-Yee Liangf Purpose. Many ocular measurements are more alike between

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Understand goal of measurement and definition of accuracy Describe the threats to causal

More information

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies Observational Study Designs Denise Boudreau, PhD Center for Health Studies Group Health Cooperative Today Review cohort studies Case-control studies Design Identifying cases and controls Measuring exposure

More information

Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study

Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study 1 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands 2 Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands 3 Department of Public Health and

More information

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E. Grobbee,

More information

Mortality following acute myocardial infarction (AMI) in

Mortality following acute myocardial infarction (AMI) in In-Hospital Mortality Among Patients With Type 2 Diabetes Mellitus and Acute Myocardial Infarction: Results From the National Inpatient Sample, 2000 2010 Bina Ahmed, MD; Herbert T. Davis, PhD; Warren K.

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Does Hysterectomy Lead to Weight Gain or Does Overweight Lead to Hysterectomy?

Does Hysterectomy Lead to Weight Gain or Does Overweight Lead to Hysterectomy? Dr Janneke BERECKI D Fitzgerald, J Berecki, R Hockey and A Dobson 1 1 School of Population Health, Faculty of Health Sciences, University of Queensland, Herston, QLD, Australia Does Hysterectomy Lead to

More information

breast cancer; relative risk; risk factor; standard deviation; strength of association

breast cancer; relative risk; risk factor; standard deviation; strength of association American Journal of Epidemiology The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:

More information

Introduction. P. M. NILSSON, J.-Å. NILSSON & G. BERGLUND Department of Medicine, University Hospital, Malmö, Sweden

Introduction. P. M. NILSSON, J.-Å. NILSSON & G. BERGLUND Department of Medicine, University Hospital, Malmö, Sweden Journal of Internal Medicine 2004; 255: 229 235 Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmö Preventive Project P.

More information

Controlling Bias & Confounding

Controlling Bias & Confounding Controlling Bias & Confounding Chihaya Koriyama August 5 th, 2015 QUESTIONS FOR BIAS Key concepts Bias Should be minimized at the designing stage. Random errors We can do nothing at Is the nature the of

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information

The Impact of Relative Standards on the Propensity to Disclose. Alessandro Acquisti, Leslie K. John, George Loewenstein WEB APPENDIX

The Impact of Relative Standards on the Propensity to Disclose. Alessandro Acquisti, Leslie K. John, George Loewenstein WEB APPENDIX The Impact of Relative Standards on the Propensity to Disclose Alessandro Acquisti, Leslie K. John, George Loewenstein WEB APPENDIX 2 Web Appendix A: Panel data estimation approach As noted in the main

More information

Setting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA.

Setting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project

More information

Epidemiologic Study Designs. (RCTs)

Epidemiologic Study Designs. (RCTs) Epidemiologic Study Designs Epidemiologic Study Designs Experimental (RCTs) Observational Analytical Descriptive Case-Control Cohort + cross-sectional & ecologic Epidemiologic Study Designs Descriptive

More information

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Record Status This is a critical abstract of an economic evaluation

More information

Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998

Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 CARDIOVASCULAR DISEASE is the leading cause of death in Australia, causing more than 40% of all deaths in 1998. 1 Cardiac rehabilitation

More information

What is the value of a family history of premature cardiovascular disease in predicting increased risk of cardiovascular disease?

What is the value of a family history of premature cardiovascular disease in predicting increased risk of cardiovascular disease? NZHTA EVIDENCE TABLES 10 January 2003 What is the value of a family history of premature cardiovascular disease in predicting increased risk of cardiovascular disease? A critical appraisal of the literature

More information

Confounding and Bias

Confounding and Bias 28 th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Barcelona, Spain August 22, 2012 Confounding and Bias Tobias Gerhard, PhD Assistant Professor, Ernest Mario School

More information

Summary HTA. HTA-Report Summary

Summary HTA. HTA-Report Summary Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,

More information

Outline. Case control studies. Study Designs. Case Control Study. Start with OUTCOME Go backwards Check for EXPOSURE. Experimental studies

Outline. Case control studies. Study Designs. Case Control Study. Start with OUTCOME Go backwards Check for EXPOSURE. Experimental studies Outline Case control studies Study Designs Experimental studies Observational studies Analytic studies Descriptive studies Randomized Controlled trials Case control Cohort Cross sectional Case Control

More information

Considering depression as a risk marker for incident coronary disease

Considering depression as a risk marker for incident coronary disease Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow

More information

Epidemiologic Methods and Counting Infections: The Basics of Surveillance

Epidemiologic Methods and Counting Infections: The Basics of Surveillance Epidemiologic Methods and Counting Infections: The Basics of Surveillance Ebbing Lautenbach, MD, MPH, MSCE University of Pennsylvania School of Medicine Nothing to disclose PENN Outline Definitions / Historical

More information

Reducing low-density lipoprotein cholesterol treating to target and meeting new European goals

Reducing low-density lipoprotein cholesterol treating to target and meeting new European goals European Heart Journal Supplements (2004) 6 (Supplement A), A12 A18 Reducing low-density lipoprotein cholesterol treating to target and meeting new European goals University of Sydney, Sydney, NSW, Australia

More information

Recent developments in mortality

Recent developments in mortality Recent developments in mortality Richard Willets Willets Consulting Recent developments in mortality Patterns of aggregate mortality change Underlying causes Heart disease Lung cancer Other cancers Patterns

More information

Family history, longevity, and the risk of coronary heart disease: the PRIME study

Family history, longevity, and the risk of coronary heart disease: the PRIME study Family history, longevity, and the risk of coronary heart disease: the PRIME study Yarnell, J., Yu, S. C., Patterson, C., Cambien, F., Arveiler, D., Amouyel, P.,... Ducimetiere, P. (2003). Family history,

More information

The importance of both low-density lipoprotein

The importance of both low-density lipoprotein Improving the Prediction of Cardiovascular Risk: Interaction Between LDL and HDL Cholesterol Steven A. Grover, 1,2,3,4 Marc Dorais, 1,3 and Louis Coupal 1,3 Background. The ratio of total cholesterol to

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

University of Wollongong. Research Online. Australian Health Services Research Institute

University of Wollongong. Research Online. Australian Health Services Research Institute University of Wollongong Research Online Australian Health Services Research Institute Faculty of Business 2011 Measurement of error Janet E. Sansoni University of Wollongong, jans@uow.edu.au Publication

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

W e have previously described the disease impact

W e have previously described the disease impact 606 THEORY AND METHODS Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies R F Heller, A J Dobson, J Attia, J Page... See end of article for authors

More information

Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy Research

Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy Research 2012 CCPRC Meeting Methodology Presession Workshop October 23, 2012, 2:00-5:00 p.m. Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy

More information

Familial risk assessment for early-onset coronary heart disease

Familial risk assessment for early-onset coronary heart disease August 2006 Vol. 8 No. 8 article Familial risk assessment for early-onset coronary heart disease Maren T. Scheuner, MD, MPH 1,2, William C. Whitworth, MPH 2, Henraya McGruder, PhD, MS 3, Paula W. Yoon,

More information

Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions

Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions DOI 10.1007/s10557-009-6162-y Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions Michel Romanens & Franz Ackermann

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 117 No 1190 ISSN 1175 8716 Smoking in a New Zealand university student sample Kypros Kypri and Joanne Baxter Abstract Aims The aims of this study were to estimate the

More information

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial J-curve Revisited An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial Sripal Bangalore, MD, MHA, Franz H Messerli, MD, Chuan-Chuan Wun, PhD, Andrea L. Zuckerman,

More information

Confounding and Interaction

Confounding and Interaction Confounding and Interaction Why did you do clinical research? To find a better diagnosis tool To determine risk factor of disease To identify prognosis factor To evaluate effectiveness of therapy To decide

More information

Biostatistics and Epidemiology Step 1 Sample Questions Set 1

Biostatistics and Epidemiology Step 1 Sample Questions Set 1 Biostatistics and Epidemiology Step 1 Sample Questions Set 1 1. A study wishes to assess birth characteristics in a population. Which of the following variables describes the appropriate measurement scale

More information

Measure of Association Examples of measure of association

Measure of Association Examples of measure of association Measure of Association Examples of measure of association Epidemiologists usually use relative differences to assess causal association (Table 3-1). Table 3 1 Types of Measures of Association Used in Analytic

More information

RESEARCH. Katrina Wilcox Hagberg, 1 Hozefa A Divan, 2 Rebecca Persson, 1 J Curtis Nickel, 3 Susan S Jick 1. open access

RESEARCH. Katrina Wilcox Hagberg, 1 Hozefa A Divan, 2 Rebecca Persson, 1 J Curtis Nickel, 3 Susan S Jick 1. open access open access Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

More information

Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance

Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance CLINICAL PRACTICE Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance John MF. Adam*, Daniel Josten** ABSTRACT The American Diabetes Association has strongly recommended that fasting

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study Laurent Azoulay PhD 1,2, Sophie Dell Aniello MSc 1, Teresa

More information

An Introduction to Epidemiology

An Introduction to Epidemiology An Introduction to Epidemiology Wei Liu, MPH Biostatistics Core Pennington Biomedical Research Center Baton Rouge, LA Last edited: January, 14 th, 2014 TABLE OF CONTENTS Introduction.................................................................

More information

article MATERIALS AND METHODS

article MATERIALS AND METHODS May/June 2004 Vol. 6 No. 3 article Family history of heart disease and cardiovascular disease risk-reducing behaviors Margaret E. McCusker, MD, MS 1, Paula W. Yoon, ScD, MPH 2, Marta Gwinn, MD, MPH 2,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Moran A, Zhao D, Gu D, et al. The Future Impact of Population

More information

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform? Journal of the American College of Cardiology Vol. 41, No. 9, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00187-6

More information

Dyslipidemia in women: Who should be treated and how?

Dyslipidemia in women: Who should be treated and how? Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of

Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of social class across the life-course in a population-based study of older men Sheena E Ramsay, MPH 1, Peter H Whincup,

More information

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example Main objective of Epidemiology Inference to a population Example: Treatment of hypertension: Research question (hypothesis): Is treatment A better than treatment B for patients with hypertension? Study

More information

Cascade Screening for FH: the U.S. experience

Cascade Screening for FH: the U.S. experience Cascade Screening for FH: the U.S. experience Paul N. Hopkins, MD, MSPH Professor of Internal Medicine Cardiovascular Genetics University of Utah Disclosures Consultant Genzyme, Amgen, Regeneron Research

More information

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis

More information

Aggregation of psychopathology in a clinical sample of children and their parents

Aggregation of psychopathology in a clinical sample of children and their parents Aggregation of psychopathology in a clinical sample of children and their parents PA R E N T S O F C H I LD R E N W I T H PSYC H O PAT H O LO G Y : PSYC H I AT R I C P R O B LEMS A N D T H E A S SO C I

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,

More information

Child centred approach to climate change and health adaptation through schools : A randomised intervention trial in Bangladesh

Child centred approach to climate change and health adaptation through schools : A randomised intervention trial in Bangladesh Child centred approach to climate change and health adaptation through schools : A randomised intervention trial in Bangladesh Md Iqbal Kabir 1,2*, Md Bayzidur Rahman 3, Wayne Smith 1, Mirza Afreen Fatima

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

SESSION 3 11 AM 12:30 PM

SESSION 3 11 AM 12:30 PM SESSION 3 11 AM 12:30 PM for the Primary Prevention of Cardiovascular Disease: A Personalized Approach SPEAKER Samia Mora MD, MHS Presenter Disclosure Information The following relationships exist related

More information

Purpose. Study Designs. Objectives. Observational Studies. Analytic Studies

Purpose. Study Designs. Objectives. Observational Studies. Analytic Studies Purpose Study Designs H.S. Teitelbaum, DO, PhD, MPH, FAOCOPM AOCOPM Annual Meeting Introduce notions of study design Clarify common terminology used with description and interpretation of information collected

More information

Source of effectiveness data The effectiveness evidence came from a review of published studies and the authors' assumptions.

Source of effectiveness data The effectiveness evidence came from a review of published studies and the authors' assumptions. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond Tice J A, Ross E, Coxson P G, Rosenberg

More information

Is There An Association?

Is There An Association? Is There An Association? Exposure (Risk Factor) Outcome Exposures Risk factors Preventive measures Management strategy Independent variables Outcomes Dependent variable Disease occurrence Lack of exercise

More information

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly?

More information

MONITORING UPDATE. Authors: Paola Espinel, Amina Khambalia, Carmen Cosgrove and Aaron Thrift

MONITORING UPDATE. Authors: Paola Espinel, Amina Khambalia, Carmen Cosgrove and Aaron Thrift MONITORING UPDATE An examination of the demographic characteristics and dietary intake of people who meet the physical activity guidelines: NSW Population Health Survey data 2007 Authors: Paola Espinel,

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

inter.noise 2000 The 29th International Congress and Exhibition on Noise Control Engineering August 2000, Nice, FRANCE

inter.noise 2000 The 29th International Congress and Exhibition on Noise Control Engineering August 2000, Nice, FRANCE Copyright SFA - InterNoise 2000 1 inter.noise 2000 The 29th International Congress and Exhibition on Noise Control Engineering 27-30 August 2000, Nice, FRANCE I-INCE Classification: 6.2 ASSOCIATION BETWEEN

More information

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 DETAILED COURSE OUTLINE Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 Hal Morgenstern, Ph.D. Department of Epidemiology UCLA School of Public Health Page 1 I. THE NATURE OF EPIDEMIOLOGIC

More information

I t is well established that non-insulin dependent diabetes is

I t is well established that non-insulin dependent diabetes is 1398 CARDIOVASCULAR MEDICINE Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease S G Wannamethee, A G Shaper, L Lennon... See end of article

More information

Analyzing diastolic and systolic blood pressure individually or jointly?

Analyzing diastolic and systolic blood pressure individually or jointly? Analyzing diastolic and systolic blood pressure individually or jointly? Chenglin Ye a, Gary Foster a, Lisa Dolovich b, Lehana Thabane a,c a. Department of Clinical Epidemiology and Biostatistics, McMaster

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Evolving patterns of tobacco use in northern Sweden

Evolving patterns of tobacco use in northern Sweden Journal of Internal Medicine 2003; 253: 660 665 Evolving patterns of tobacco use in northern Sweden B. RODU 1, B. STEGMAYR 2, S. NASIC 2, P. COLE 3 & K. ASPLUND 2 From the 1 Department of Pathology, School

More information

C. Packham 1, D. Gray 2, P. Silcocks 3 and J. Hampton 2. Introduction

C. Packham 1, D. Gray 2, P. Silcocks 3 and J. Hampton 2. Introduction European Heart Journal (2000) 21, 213 219 Article No. euhj.1999.1758, available online at http://www.idealibrary.com on Identifying the risk of death following hospital discharge in patients admitted with

More information

A lthough the hazards of smoking are well described,

A lthough the hazards of smoking are well described, 702 RESEARCH REPORT Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes?

Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes? Late Breaking Clinical Trial Session at AHA 2017 Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes? The REAL-CAD Study in 13,054 Patients With Stable Coronary Artery Disease Takeshi

More information

Bias and confounding special issues. Outline for evaluation of bias

Bias and confounding special issues. Outline for evaluation of bias EPIDEMIOLOGI BIAS special issues and discussion of paper April 2009 Søren Friis Institut for Epidemiologisk Kræftforskning Kræftens Bekæmpelse AGENDA Bias and confounding special issues Confounding by

More information

Type of intervention Primary prevention; secondary prevention. Economic study type Cost-effectiveness analysis and cost utility analysis.

Type of intervention Primary prevention; secondary prevention. Economic study type Cost-effectiveness analysis and cost utility analysis. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients Milne R J, Hoorn S V, Jackson R T Record

More information

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Steven E. Nissen MD Chairman, Department of Cardiovascular Medicine Cleveland Clinic Disclosure Consulting: Many pharmaceutical

More information

Title: Home Exposure to Arabian Incense (Bakhour) and Asthma Symptoms in Children: A Community Survey in Two Regions in Oman

Title: Home Exposure to Arabian Incense (Bakhour) and Asthma Symptoms in Children: A Community Survey in Two Regions in Oman Author's response to reviews Title: Home Exposure to Arabian Incense (Bakhour) and Asthma Symptoms in Children: A Community Survey in Two Regions in Oman Authors: Omar A Al-Rawas (orawas@squ.edu.om) Abdullah

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information